Compare AMLX & STBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMLX | STBA |
|---|---|---|
| Founded | 2014 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2022 | N/A |
| Metric | AMLX | STBA |
|---|---|---|
| Price | $13.15 | $42.14 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 4 |
| Target Price | $17.43 | ★ $41.25 |
| AVG Volume (30 Days) | ★ 1.2M | 201.1K |
| Earning Date | 11-06-2025 | 01-29-2026 |
| Dividend Yield | N/A | ★ 3.42% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.46 |
| Revenue | N/A | ★ $391,893,000.00 |
| Revenue This Year | N/A | $7.36 |
| Revenue Next Year | N/A | $5.02 |
| P/E Ratio | ★ N/A | $12.18 |
| Revenue Growth | N/A | ★ 1.21 |
| 52 Week Low | $2.60 | $30.84 |
| 52 Week High | $16.96 | $43.64 |
| Indicator | AMLX | STBA |
|---|---|---|
| Relative Strength Index (RSI) | 43.47 | 70.29 |
| Support Level | $12.69 | $40.05 |
| Resistance Level | $15.06 | $42.52 |
| Average True Range (ATR) | 0.76 | 0.95 |
| MACD | -0.16 | 0.19 |
| Stochastic Oscillator | 17.77 | 89.28 |
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.
S&T Bancorp Inc is a bank holding company. The company operates in five markets including Western Pennsylvania, Eastern Pennsylvania, Northeast Ohio, Central Ohio and Upstate New York. The company provides financial services with retail and commercial banking products, cash management services, trust and brokerage services. It operates only in one segment which is Community Banking. The company earns revenue from interest on loans and securities and fees charged for financial services provided to its customers.